Cited by 69Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionHormonal Regulation and Hypertension

Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study

Open access
Smith, Steven M., Huo, Tianyao, Delia Johnson, B., Bittner, Vera, Kelsey, Sheryl F., Vido Thompson, Diane, Noel Bairey Merz, C., Pepine, Carl J. +1 more·2014·Journal of the American Heart Association

Abstract

Background: Women are more likely than men to develop resistant hypertension, which is associated with excess risk of major adverse outcomes; however, the impact of resistant hypertension in women with ischemia has not been explicitly studied. In this Women's Ischemia Syndrome Evaluation ( WISE ) analysis, we assessed long‐term adverse outcomes associated with apparent treatment‐resistant hypertension ( aTRH ) among women with suspected myocardial ischemia referred for coronary angiography. Methods and Results: Women (n=927) were grouped according to baseline blood pressure ( BP ): normotensive (no hypertension history, BP <140/90 mm Hg, no antihypertensive drugs); controlled ( BP <140/90 mm Hg and a hypertension diagnosis or on 1 to 3 drugs); uncontrolled ( BP ≥140/90 mm Hg on ≤2 drugs); or aTRH ( BP ≥140/90 mm Hg on 3 drugs or anyone on ≥4 drugs). Adverse outcomes (first occurrence of death [any cause], nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure or angina) were collected over 10 years of follow‐up. Apparent treatment‐resistant hypertension prevalence was 10.4% among those with hypertension. Women with aTRH had a greater incidence of adverse outcomes, compared with normotensive women (adjusted hazard ratio [ HR], 3.25; 95% confidence interval [ CI], 1.94 to 5.43), and women with controlled ( HR, 1.77; 95% CI, 1.26 to 2.49) and uncontrolled ( HR, 1.62; 95% CI, 1.15 to 2.27) hypertension; outcome differences were evident early in follow‐up. Risk of all‐cause death was greater in the aTRH group, compared to the normotensive women and women with controlled and uncontrolled hypertension. Conclusions: In this cohort of women with evidence of ischemia, aTRH was associated with a profoundly increased long‐term risk of major adverse events, including death, that emerged early during follow‐up.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.113.000660

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Smith, S. M., Huo, T., Delia Johnson, B., Bittner, V., Kelsey, S. F., Vido Thompson, D., Noel Bairey Merz, C., Pepine, C. J., & Cooper‐DeHoff, R. M.
Affiliations
  • University of Florida (US)
  • Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
  • University of Alabama at Birmingham (US)
  • University of Pittsburgh (US)
  • Allegheny General Hospital, Pittsburgh, PA
  • Barbara Streisand Women's Heart Center, Cedars‐Sinai Heart Institute, Los Angeles, CA
Venue
Journal of the American Heart Association
Published
2014-01-27
Volume
3
Issue
1
Pages
e000660-e000660
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2125594639
Cited by
69
References
45
Citations by year
2026: 1 · 2025: 1 · 2024: 6 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 8 · 2019: 3 · 2018: 9 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 3
FWCI
5.26
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Journal of the American Heart Association (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01hv068164-006, n01hv068162-009, n01hv068161-005, UL1TR000124, n01hv068163-006)
  • U.S. Public Health Service (U0164829)
  • National Institute on Aging (R03AG032631)
  • National Heart, Lung, and Blood Institute (U01HL064829, N01-HV68162, N01 HV 68161, U01HL649141, T32HL069751, N01HV68163, U01 HL649241, T32HL69751, R01HL090957, N01-HV68164)
  • National Center for Research Resources (M01RR000425, M01-RR00425)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
apparent treatment-resistant hypertension, women, myocardial ischemia, coronary artery disease, cardiovascular risk, mortality, major adverse cardiovascular events, all-cause mortality, myocardial infarction, stroke, heart failure, angina pectoris, antihypertensive therapy, WISE study
MeSH terms
Adult, Aged, Angina Pectoris, Antihypertensive Agents, Blood Pressure, Drug Resistance, Drug Therapy, Combination, Female, Heart Failure, Hospitalization, Humans, Hypertension, Middle Aged, Myocardial Infarction, Prognosis, Risk Factors, Sex Factors, Time Factors, United States, Proportional Hazards Models, Coronary Angiography, Myocardial Ischemia, Stroke, Kaplan-Meier Estimate, National Heart, Lung, and Blood Institute (U.S.)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review